A 35-year-old nulliparous woman with regular menses and no systemic disease requests a long-acting reversible contraceptive. She has no contraindications to any method. Which IUCD is the drug of choice for her?

Explanation

## Copper T 380A as First-Line IUCD in Nulliparous Women with Normal Menses **Key Point:** Copper T 380A is the drug of choice for nulliparous women with normal menstrual patterns and no contraindications, as it offers maximum contraceptive efficacy, long duration, and no systemic hormonal effects. ### Why Copper T 380A is Preferred in This Scenario 1. **Highest contraceptive efficacy** → Pearl index 0.8 per 100 woman-years (comparable to tubal ligation) 2. **Longest duration** → 10 years of protection 3. **No systemic hormones** → ideal for women concerned about hormonal effects 4. **Cost-effective** → cheaper than LNG-IUS over 10-year span 5. **Suitable for nulliparous women** → modern IUCDs are safe in nulliparous women (WHO 2012 update) ### Decision Algorithm: Which IUCD to Choose? ```mermaid flowchart TD A[Woman seeking IUCD]:::outcome --> B{Menorrhagia or<br/>dysmenorrhea?}:::decision B -->|Yes| C[LNG-IUS]:::action B -->|No| D{Concern about<br/>hormones?}:::decision D -->|Yes| E[Copper T 380A]:::action D -->|No| F{Nulliparous?}:::decision F -->|Yes| G[Copper T 380A<br/>or LNG-IUS]:::action F -->|No| H[Copper T 380A<br/>preferred]:::action ``` ### Comparison: Copper T 380A vs. LNG-IUS in Asymptomatic Women | Feature | Copper T 380A | LNG-IUS | |---------|---------------|----------| | **Efficacy (Pearl index)** | 0.8 | 0.2 | | **Duration** | 10 years | 5–7 years | | **Systemic hormones** | None | Minimal (local) | | **Menstrual bleeding** | Slight increase | Marked decrease | | **Cost (10-year)** | Lower | Higher | | **Ideal indication** | Normal menses, no hormonal concerns | Menorrhagia, dysmenorrhea | **High-Yield:** In the **absence of menorrhagia or dysmenorrhea**, copper IUCD is preferred because: - No need for hormonal intervention - Longer duration (10 vs. 5–7 years) - Lower overall cost - Equally effective contraceptive **Clinical Pearl:** The 2012 WHO update removed "nulliparity" as a contraindication to IUCDs. Modern evidence supports IUCD use even in nulliparous women, making Copper T 380A a first-line choice in this patient. **Warning:** Do not confuse the indications — LNG-IUS is for **symptomatic** women (menorrhagia/dysmenorrhea); Copper T 380A is for **asymptomatic** women with normal menses.